ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "Acuitas co-founder Pieter Cullis on breakthrough vaccine innovation"
Episode Synopsis
A made-in-B.C. innovation is playing a critical role in the Pfizer-BioNTech COVID-19 vaccine rolling out across the globe. Lipid nanoparticle technology — or LNP — developed by Vancouver’s Acuitas Therapeutics is one of the key factors allowing the vaccine to work. Acuitas co-founder Pieter Cullis joins BIV Today to break it down. Tyler Orton hosts.See omnystudio.com/listener for privacy information.
More episodes of the podcast BIV Today
The latest IT trends for Canadian businesses
02/05/2024
STEMCELL Technologies founder Allen Eaves
03/08/2023
In God we trust